Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations.
about
Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital settingCommunity-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicArginine catabolic mobile element encoded speG abrogates the unique hypersensitivity of Staphylococcus aureus to exogenous polyaminesQuarantine, isolation, and cohorting: from cholera to KlebsiellaInfectious diseases. Annual review of significant publications.Structural Insights into the Anti-methicillin-resistant Staphylococcus aureus (MRSA) Activity of CeftobiproleIdentification of an Antimicrobial Agent Effective against Methicillin-Resistant Staphylococcus aureus Persisters Using a Fluorescence-Based Screening StrategyCommunity-acquired methicillin-resistant Staphylococcus aureus: the new face of an old foe?Infections caused by multidrug resistant organisms are not associated with overall, all-cause mortality in the surgical intensive care unit: the 20,000 foot view.In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureusPhage pattern-specific oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus in U.S. hospitals: epidemiological significance.Changes in the nasal colonization with methicillin-resistant Staphylococcus aureus in children: 2004-2009Community-associated methicillin-resistant Staphylococcus aureus: new bug, old drugs.Disinfection of football protective equipment using chlorine dioxide produced by the ICA TriNova system.Positive nasal culture of methicillin-resistant Staphylococcus aureus (MRSA) is a risk factor for surgical site infection in orthopedics.A model-based analysis: what potential could there be for a S. aureus vaccine in a hospital setting on top of other preventative measures?Modeling the transmission of community-associated methicillin-resistant Staphylococcus aureus: a dynamic agent-based simulation.Transduction of methicillin resistance in Staphylococcus aureus: recipient effectiveness and beta-lactamase productionWaves of resistance: Staphylococcus aureus in the antibiotic era.National athletic trainers' association position statement: skin diseases.Use of the diagnostic bacteriology laboratory: a practical review for the clinician.Genetically divergent methicillin-resistant Staphylococcus aureus and sec-dependent mastitis of dairy goats in Taiwan.Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS).Methicillin-resistant Staphylococcus aureus: a pervasive pathogen highlights the need for new antimicrobial development.Use of oligoarrays for characterization of community-onset methicillin-resistant Staphylococcus aureus.Detection of methicillin-resistant Staphylococcus aureus strains resistant to multiple antibiotics and carrying the Panton-Valentine leukocidin genes in an Algiers hospital.Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients.Structural and functional characterization of methicillin-resistant Staphylococcus aureus's class IIb fructose 1,6-bisphosphate aldolase.Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, CaliforniaMRSA and the environment: implications for comprehensive control measures.Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis.Variation in the susceptibility of strains of Staphylococcus aureus to oxacillin, cephalothin, and gentamicinMethicillin-resistant staphylococci: detection methods and treatment of infections.Predominant Dissemination of PVL-Negative CC89 MRSA with SCCmec Type II in Children with Impetigo in Japan.Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections.Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and -resistant staphylococci.Molecular Types of Methicillin-Resistant Staphylococcus aureus and Methicillin-Sensitive S. aureus Strains Causing Skin and Soft Tissue Infections and Nasal Colonization, Identified in Community Health Centers in New York City.Antibiotic Susceptibility of Staphylococcus aureus in Atopic Dermatitis: Current Prevalence of Methicillin-Resistant Staphylococcus aureus in Korea and Treatment StrategiesPrevention of Recurrent Staphylococcal Skin InfectionsCommunity-associated methicillin-resistant Staphylococcus aureus, Minnesota, 2000-2003.
P2860
Q24186422-A6320646-6FF2-4EAA-B1C7-F0D7D7499B83Q24614464-F9A7B840-0FC6-4142-87EA-B737663CA448Q24635354-EB94995F-DE8F-48E8-8738-4D148F48C3B7Q26997796-BF1F9F2E-8DC9-4518-9311-BD14B4F20458Q27486429-66FAE303-9AD0-4A29-AD83-2DCD03BB9195Q27670836-5B6A6282-4F40-44BB-934B-2472B1E53DFDQ28547787-7FCDC296-E358-4027-963A-53ED44633A60Q30353780-E0DCE16A-6CF4-4B0E-ACF4-3B0B3B798CF2Q30419577-8CEB5ADB-565F-41EE-92DA-0D73132CF9A0Q30451373-2C93D321-8436-4A4B-A809-66A7F1CE4CF0Q30451530-9EB579C5-6021-4CF4-800F-AE63F0EE37B7Q30994842-6261DE5F-49E7-486D-8BD3-D604B3C5DB29Q33245188-85B427CB-3CD7-43BD-B7D5-7AD94651EC0CQ33500856-CC07772A-85F3-435B-9F4F-D704D8E6574BQ33659990-8790D5B4-8DE1-4145-A0FE-ED9177C305C4Q33714965-4A6460C5-63A9-4998-BBA6-03AD572FE40EQ33727930-B58DFF6A-E1E4-4B18-8E86-5E8F44E49A2FQ33733124-FDFD49A5-8132-48E0-ADE3-ADD35899B229Q33854398-7EDB1356-0D2C-4B42-A506-F4792E91A2B7Q33984713-24AA599E-657D-4FA6-92B3-E3F97D5EC474Q34164527-DAF75389-6408-447A-8994-894B3C70D328Q34210919-5C6F81F9-D1FB-423B-BA20-99E223A008ADQ34261329-6D735DC6-B304-4310-AC4C-4E1E47763E10Q34407240-505ABA65-0A3F-4D18-9BB4-2393DC92383EQ34431703-B23F55FE-C73D-4A53-A0E8-2E4E9E8B7D9FQ34509820-1AA4F37B-BA36-4C88-97FE-4CC7C8B4A3A1Q34560162-E730EB65-5CCB-4B14-AE16-2B037F4A0803Q34680207-D504B2D3-ECDB-4E39-AC17-44CDACAD94F0Q34719851-68691F6C-1E2A-4DDA-AE26-9C4237FD445CQ34750014-93944841-9D85-4ECF-8DF7-F1312C46A331Q34885043-D5873C37-4F50-471A-A619-F90C56FB0652Q34981825-4849A97A-0742-4F23-B076-C7B86BB5FCE4Q35566190-B074270C-FBAC-4901-B7E4-8BCF1AB34732Q35609122-204FC5E0-78F3-48B0-B645-43A61D347C85Q35638010-D25CC155-D85E-4F5A-81E2-9296926FB52CQ35657468-9AA3F86F-6FC9-4A08-848A-560A0D8F5F8EQ35868639-AD96727F-1085-408F-8686-4238EA926F87Q35931908-1A1C627C-7D6F-48AB-8F9E-AD90D2524850Q36005464-6FE2ACEF-71B5-4FE3-83C6-DD1BDA165F3BQ36006683-0E823B16-DC45-4AFA-9455-7202B68F899F
P2860
Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations.
description
1968 nî lūn-bûn
@nan
1968 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1968 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1968年の論文
@ja
1968年学术文章
@wuu
1968年学术文章
@zh-cn
1968年学术文章
@zh-hans
1968年学术文章
@zh-my
1968年学术文章
@zh-sg
1968年學術文章
@yue
name
Methicillin-resistant Staphylo ...... nd epidemiologic observations.
@ast
Methicillin-resistant Staphylo ...... nd epidemiologic observations.
@en
Methicillin-resistant Staphylo ...... nd epidemiologic observations.
@nl
type
label
Methicillin-resistant Staphylo ...... nd epidemiologic observations.
@ast
Methicillin-resistant Staphylo ...... nd epidemiologic observations.
@en
Methicillin-resistant Staphylo ...... nd epidemiologic observations.
@nl
prefLabel
Methicillin-resistant Staphylo ...... nd epidemiologic observations.
@ast
Methicillin-resistant Staphylo ...... nd epidemiologic observations.
@en
Methicillin-resistant Staphylo ...... nd epidemiologic observations.
@nl
P2093
P1476
Methicillin-resistant Staphylo ...... nd epidemiologic observations.
@en
P2093
Barrett FF
McGehee RF Jr
P304
P356
10.1056/NEJM196808292790901
P407
P577
1968-08-01T00:00:00Z